Stock SPHDF SANTHERA PHARMACEUTICALS HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Santhera Pharmaceuticals Holding AG OTC Markets

Equities

SPHDF

CH1276028821

Market Closed - OTC Markets
Other stock markets
 17:23:09 22/02/2024 GMT 		5-day change 1st Jan Change
11.7 USD +4.00% Intraday chart for Santhera Pharmaceuticals Holding AG -.--% -.--%
06-19 Transcript : Santhera Pharmaceuticals Holding AG - Special Call
06-18 Santhera Secures CHF69 Million Financing for Bond Repayment, Cash Runway Extension MT

Transcripts

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Transcript : Santhera Pharmaceuticals Holding AG - Special Call
Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024
Transcript : Santhera Pharmaceuticals Holding AG, H1 2023 Earnings Call, Sep 07, 2023
Transcript : Santhera Pharmaceuticals Holding AG - Special Call
Transcript : Santhera Pharmaceuticals Holding AG, 2022 Earnings Call, Apr 27, 2023
Transcript : Santhera Pharmaceuticals Holding AG, H1 2022 Earnings Call, Nov 07, 2022
Transcript : Santhera Pharmaceuticals Holding AG, 2021 Earnings Call, Jun 10, 2022
Transcript : Santhera Pharmaceuticals Holding AG - Special Call
Transcript : Santhera Pharmaceuticals Holding AG, H1 2021 Earnings Call, Sep 22, 2021
Transcript : Santhera Pharmaceuticals Holding AG - Special Call
Transcript : Santhera Pharmaceuticals Holding AG, 2020 Earnings Call, Apr 29, 2021
Transcript : Santhera Pharmaceuticals Holding AG - Special Call
Transcript : Santhera Pharmaceuticals Holding AG, H1 2020 Earnings Call, Sep 08, 2020
Transcript : Santhera Pharmaceuticals Holding AG - Special Call
Transcript : Santhera Pharmaceuticals Holding AG, 2019 Earnings Call, Mar 24, 2020
Santhera Pharmaceuticals Holding AG Provides Earnings Guidance for the Full Year 2019
CI
Santhera Pharmaceuticals Reports Preliminary Unaudited Revenues for the Year 2017; Provides Earnings Guidance for the Year 2017 and Sales Guidance for the Year 2018
CI
Santhera Pharmaceuticals Announces Preliminary Revenue Results for the Full Year 2016; Provides Earnings Guidance for the Full Year 2016 and Sales Guidance for the Full Year 2017
CI
Santhera Pharmaceuticals Holding AG Announces Preliminary Unaudited Revenue Results for the Second Half and Full Year of 2016; Provides Earnings Guidance for the Year 2016 and Revenue Guidance for the Year 2017
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SANN Stock
  4. SPHDF Stock
  5. News Santhera Pharmaceuticals Holding AG
  6. Transcripts